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Abstract
After publication of this article (Scand J Trauma Resusc Emerg Med 23:40, 2015) , it came to light that an earlier version
had been published in error. This erratum contains the correct version of the article, which incorporates revisions
made in response to reviewer comments. Additionally, one of the authors was inadvertently omitted from the author
list. This author, Justin Yan, has been included in the corrected author list above.
Background: Transcutaneous CO2 (PtCO2) is a continuous and non-invasive measure recommended by scientific
societies in the management of respiratory distress. The objective of this study was to evaluate the correlation
between PtCO2 and arterial partial pressure of CO2 (PaCO2) by arterial blood gas analysis in emergency patients with
dyspnoea, and to determine the factors that interfere with this correlation.
Methods: From January to June 2014, all adult patients admitted to the RR with dyspnoea during business hours were
included in the study if arterial blood gas measurements were indicated. A sensor measuring the PtCO2 was attached
to the ear lobe of the patient before the gas analysis. Anamnesis, clinical and laboratory parameters were identified.
Results: Ninety patients with dyspnoea were included (104 pairs of measurements). The median (IQR) age was 79
years (69 – 85). The correlation between PtCO2 and PaCO2 was R2 = .83 (p < .001) but became lower for values of
PaCO2 above 60 mm Hg. The mean bias (± SD) between the two methods of measurement (Bland-Altman analysis)
was −1.4 mm Hg (± 7.7) with limits of agreement from −16.4 to 13.7 mm Hg. In univariate analysis, PaO2 interfered
with this correlation. After multivariate analysis, temperature (OR = 3.01; 95 % CIs [1.16, 7.80]) and PaO2 (OR = 1.22;
95 % CIs [1.02, 1.47]) significantly interfered with this correlation.
Conclusions: There is a significant correlation between PaCO2 and PtCO2 values for patients admitted to the
emergency department for acute respiratory failure. One limiting factor to routine use of PtCO2 measurements in the
emergency department is the presence of hyperthermia.
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Background
This is a corrected version of the previously published
article [1]. Arterial blood gas monitoring is crucial for
management of patients with respiratory failure [2]. The
gold standard technique involves an arterial puncture
which is invasive, time-consuming, and only gives results
at one point in time [3, 4]. Moreover, the delay in wait-
ing for the results of blood gas analysis does not allow
for real-time adaptation of oxygen therapy or mechanical
ventilation. Oxygen saturation by pulse oximetry (SpO2)
is widely used as a surrogate of arterial oxygen satura-
tion (SaO2) [5]. Similarly, end tidal CO2 (EtCO2) allows
for an indirect, but reliable and continuous assessment of
arterial pCO2 for mechanically ventilated patients. How-
ever, for non-ventilated patients, assessment of EtCO2 is
more complex, less accurate, and often impossible. For
these patients, the recently recommended [6, 7] tran-
scutaneous monitoring of carbon dioxide (PtCO2) could
represent an alternative for immediate and continuous
assessment of pCO2. Numerous studies of both children
[8, 9] and adults [10–12] have found a good correlation
between PaCO2 and PtCO2. Yet in the specific setting of
the emergency department (ED) resuscitation room (RR),
PtCO2 has been poorly studied. Themain objective of this
study was to investigate the relationship between mea-
sures of PtCO2 and PaCO2 for patients admitted to the
ED RR. The secondary objective was to determine the




We conducted this single-center prospective observa-
tional study from January to June 2014 in the ED of Nîmes
University Hospital, France. This study was reviewed
and approved by our Institutional Review Board (num-
ber: 13/06–02) and was declared to and approved by the
national commission for data processing and civil liber-
ties. All patients provided written informed consent. This
study is in compliance with the Helsinki Declaration.
Study population
All adult patients admitted to the RR with dyspnoea dur-
ing business hours (from 9:00 to 17:00, weekend excluded)
were included in the study if arterial blood gas measure-
ments were indicated. In our ED, patients are admitted
to the RR if they are level 1 or level 2 according to the
Canadian Triage and Acuity Scale (CTAS). Thus, patients
with dyspnoea are admitted to the RR if they suffered from
severe respiratory distress, asthma, or important dysp-
noea. Definition of CTAS level 1 and level 2 for dyspnoea
are specified in Appendix 1. Exclusion criteria were incor-
rect installation of the sensor, signal abnormality on the
monitor, and backup error on the memory of the device.
Measurement
The PtCO2 measurement was performed by a Stow-
Severinghaus sensor (tc Sensor 92 by Radiometer™,
Copenhagen, Denmark). The sensor heats skin to a
temperature of 44 °C resulting in a dilatation of the
capillary bed that allows for diffusion of gases (CO2
and O2) [13]. On the sensor, carbon dioxide reacts
with water to form carbonic acid which dissociates into
H+ and HCO−3 , thereby changing pH values. These
pH changes are translated into PtCO2 value through
the Henderson-Hasselbalch formula [14]. Medical and
paramedical staff were trained in the operation and main-
tenance of the PtCO2 TOSCA monitor (Radiometer™,
Copenhagen, Denmark) before the study commenced. For
included patients, the PtCO2 sensor was attached to the
ear lobe of the patient allowing for continuous measure-
ment of PtCO2. After stabilization of the monitor to
obtain a good signal, arterial blood gases and PtCO2 mea-
surements were performed simultaneously. The medical
team was blinded to the value of PtCO2 measured.
Outcomes
The primary outcome was concordance between the
simultaneous PaCO2 and PtCO2 values. The sample size
calculation was based on the anticipated variation in the
differences between the measurements and the required
precision. Using a previous study [15] for an estimate of
the variation between the differences, a sample size of 50
patients gave a precision of ± 0.19 kPa as the limits of
agreement. The secondary outcome was to determine the
factors that interfere with this correlation. PtCO2 values
were automatically saved every ten seconds by the moni-
tor. Medical patient data were collected and entered into
an electronic database after initial collection on paper case
report forms (CRF). Blood pressure, heart rate, respira-
tory rate, blood oxygen saturation, Glasgow coma scale,
temperature, time to completion of arterial blood gases,
catecholamine use, and non-invasive ventilation or tra-
cheal intubation were recorded by the attending physician.
Characteristics of patients such as ED arrival modalities,
hospital length of stay, and biological data were collected
on the CRF.
Statistical analysis
Patient characteristics were described using qualita-
tive (frequencies and percentages) or quantitative vari-
ables (means and standard deviations or median with
interquartile ranges - depending on type of distribution)
where appropriate. The concordance between PtCO2 and
PaCO2 was evaluated by linear regression (correlation
coefficients) and Bland-Altman analysis, which deter-
mined bias, precision, and agreement of PtCO2 and
PaCO2, taking the automated analysis in the labora-
tory as the reference standard. The Pearson correlation
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coefficient was used to demonstrate the presence or
absence of a relationship between PtCO2 and PaCO2.
Relationships between measurement differences (| PaCO2-
PtCO2 |) and patient characteristics were investigated
by regression analysis. Variables related to the difference
between PtCO2 and PaCO2 in the univariate analysis
(defined by p < .1, forward selection) were further ana-
lyzed in a multivariate model (analysis of covariance).
We included PaCO2 in this model but did not included
pH or PtCO2 to avoid a collinear bias. Overall model fit
was assessed using the Hosmer-Lemeshow test. All sta-
tistical tests were two sided. A p-value less than .05 was
considered significant for all analyses.
Analyses were performed with the use of R 3.0.2 (R Core
Team 2013, R: A language and environment for statisti-
cal computing. R Foundation for Statistical Computing,
Vienna, Austria). The authors had full access to and take
full responsibility for the integrity of the data.
Results
Between January 2014 and June 2014, 102 patients were
screened for eligibility. Ninety patients were included and
analyzed with 104 PtCO2 values (Fig. 1). Table 1 shows the
patient characteristics corresponding to the 104 measure-
ments. After linear regression analysis of 104 couples of
measurements, we found a significant correlation between
PaCO2 and PtCO2 with R2 = .83 (p < .001) (Fig. 2).
The linear regression equation between the two variables
was PaCO2 = (0.81 × PtCO2) +10.86. The Bland-Altman
analysis is shown in Fig. 3. The mean bias was −1.4 mmHg
(± 7.7) and the limits of agreement (bias ± 1.96 SD)
between the two techniques were −16.4 mm Hg and
13.7 mm Hg. The Pearson’s correlation coefficient was
.94 (95 % CIs [0.87, 0.94]; p < .001). For the group with
PaC02 < 60 mm Hg, R2 = .70 (p < .001) and the
mean bias was −3.5 mm Hg (± 5.0). For the group with
PaC02 > 60 mm Hg, R2 = .57 (p < .001) and the mean
bias was 4.1 mm Hg (± 10.2).
In the univariate analysis, the only factor associated
with a difference between PaCO2 and PtCO2 was PaO2
(Table 2). In multivariate analysis with three explanatory
variables (PaCO2, PaO2, temperature), we found the tem-
perature and the PaO2 to be significantly associated with a
large difference between PaCO2 and PtCO2 (Table 2). The
higher the temperature of the patient, the greater the dif-
ference between PaCO2 and PtCO2 (Fig. 4).We developed
this model on a data set of 93 measurements (11 observa-
tions were exluded due to missingness). This model had a
non-significant Hosmer-Lemeshow chi-square goodness-
of-fit statistic.
Discussion
To our knowledge, our study is the largest cohort of PtCO2
measurements conducted in the ED. The mean bias
was −1.4 mm Hg (± 7.7) and the limits of agreement
(bias ± 1.96 SD) between the two techniques were −16.4
mm Hg and 13.7 mm Hg. There was a significant corre-
lation between PaCO2 and PtCO2 (R2 = .83; p < .001).
Because most of our patients were non-intubated, our
results highlight the feasibility and the potential benefit
of measuring PtCO2 since EtCO2 cannot easily be mon-
itored in non-intubated patients. The correlation coeffi-
cient in our study was comparable to what was shown in
a previous intensive care study (R2 = .86; p < .01) [10].
However, other studies have found a stronger correla-
tion (R2 coefficient, ranged between .91 and .99 [16–18]).
Fig. 1 Flow diagram
Bobbia et al. Scandinavian Journal of Trauma, Resuscitation and EmergencyMedicine  (2015) 23:77 Page 4 of 7
Table 1 Patients’ characteristics
Male sex, no. ( %) 51 (57)
Age, mean (± SD) - year 76 (15)
Past medical history, no. ( %)
Acute pulmonary edema 27 (29)
Chronic obstructive pulmonary disease 27 (29)
Ischemic heart disease 21 (23)
Home oxygen 16 (17)
Clinical data at admission, median (IQR)
Heart rate - beats/min. 94 (80–110)
Systolic blood pressure - mm Hg 122 (106–144)
Diastolic blood pressure - mm Hg 69 (60–78)
Respiratory rate - breaths/min. 24 (19–28)
Glasgow coma scale 15 (14–15)
Temperature - °C 37.0 (36.2–37.6)
Laboratory values, median (IQR)
PaCO2 - mm Hg 46.2 (37.6–66.8)
PtCO2 - mm Hg 47.2 (42.1–60.0)
PaO2 - mm Hg 73.5 (63.0–89.0)
pH 7.37 (7.30–7.43)
HCO3 - mEq/L 26.0 (22.8–29.7)
Base excess - mmol/L 1.9 (-1.9–5.8)
Lactate - mmol/L 1.3 (0.7–2.2)
Hemoglobin - g/dL 12.3 (10.9–13.8)
White blood cells - G/L 12.4 (7.9–15.5)
C-reactive protein 41 (8–122)
Glycemia - g/L 1.4 (1.2–1.7)
Brain natriuretic peptide - ng/L 1704 (579–6200)
Diagnosis, no. ( %)
Heart failure 25 (27)
COPD 14 (15)
Pneumonia 42 (46)
Pulmonary embolism 5 (5)
Outcome, no. ( %)
Noninvasive ventilation required 41 (45)
Intubation required 4 (4)
Admitted to hospital 61 (66)
Admitted to ICU 19 (21)
Discharged from ED 10 (11)
Death at the ED 2 (2)
Inpatient mortality 9 (10)
We assume this difference is not a consequence of the use
of various devices since most of the studies were com-
pleted with a Radiometer™device. This difference can be
explained by the selection of our patients, as only those
in the RR with acute respiratory failure were included.
Fig. 2 Linear regression between transcutaneous PtcCO2 and PaCO2.
Regression line is the continuous line, the dotted lines show the 95 %
confidence interval
Indeed, the high and extreme PaCO2 values were reported
as possibly interfering with the correlation between
PtCO2 and PaCO2 [10, 19–21]. In a study by Delerme et al.
[11], patients had a lower PaCO2 than in our study (39
mmHg vs. 46, respectively). Secondly, this difference may
result from the use of the device by many physicians.
Calibration, sensor placement and latency to reach the
plateau value of PtCO2 may differ from one physician to
another. Because some operators used the monitor less
frequently, this may have led to poorer reproducibility.
However, it also reflects our center’s daily practice and
Fig. 3 Bland-Altman representation of comparison analysis between
PaCO2 and PtcCO2 vs means of paired measurements
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Table 2 Relationships between measurement differences
(|PaCO2-PtCO2|) and patient characteristics using univariate and
multivariate analysis (ANCOVA)
Univariate analysis Multivariate analysis
Variable OR [95 % CIs] P-value OR [95 % CIs] P-value
Sex 1.61 [0.18, 14.25] .66
Past medical history
Acute pulmonary 0.29 [0.03, 2.96] .29
edema
COPD 0.60 [0.06, 6.18] .67
Ischemic heart 0.75 [0.06, 8.91] .82
disease
Home oxygen 1.01 [0.06, 16.77] .99
Heart rate 0.98 [0.94, 1.03] .40
Systolic blood 1.01 [0.97, 1.05] .60
pressure
Diastolic blood 0.97 [0.91, 1.03] .33
pressure
Respiratory rate 1.01 [0.88, 1.18] .85
Temperature 2.45 [0.93, 6.49] .07 3.01 [1.16, 7.80] .03
PaCO2 1.05 [1.00, 1.12] .06 1.06 [1.00, 1.12] .05
PtCO2 1.06 [1.00, 1.13] .06
PaO2 1.21 [1.01, 1.45] .04 1.22 [1.02, 1.47] .03
HCO3 0.96 [0.80, 1.15] .64
Base excess 0.96 [0.82, 1.12] .60
Lactate 1.44 [0.43, 4.79] .54
Hemoglobin 1.20 [0.74, 1.95] .45
White blood cells 0.91 [0.74, 1.12] .38
C-reactive protein 1.00 [0.99, 1.01] .72
Glycemia 4.70 [0.62, 35.58] .13
Brain natriuretic 1.00 [1.00, 1.00] .82
vpeptide
this issue may occur with any change of device. Thirdly,
we did not correct the arterial blood gases according to
the patient’s temperature and this may explain a portion
of the increased difference. Finally, our population was
more likely to have significant dyspnoea and therefore
agitation or diaphoresis leading to movement of the sen-
sor may have led to inaccurate measurements. Indeed,
in the Gancel et al. study [12] where the difference was
lower, the exclusion criteria were very rigorous. Authors
did not study patients with status epilepticus, confusion
or agitation. According to the authors, these criteria may
have led to the exclusion of some patients with severe
hypercapnia.
Our study found that PtCO2 values were generally
greater than PaCO2 values. Indeed, our linear regres-
sion equation is PaCO2 = (0.81 × PtCO2) + 10.86. This
overestimation is in accordance with available literature
Fig. 4 Linear regression between temperature and difference
between PaCO2 and PtCO2 (|PaCO2-PtCO2|). Regression line is the
continuous line, the dotted lines show the 95 % confidence interval
[10, 22, 23] and may have implications for patients requir-
ing non-invasive ventilation and with no arterial blood
gas reference. Thus, the recommendations highlight the
need to conduct an arterial blood gas analysis to sup-
port the correlation between PaCO2 and PtCO2 values
[6]. This issue is important given that the Bland-Altman
analysis reveals a poorer correlation for PtCO2 values
above 60 mm Hg. The value of the mean bias reported
in our study corresponds to those found in the litera-
ture (−1.4 to 4.6 mm Hg) [16, 24, 25]. The decrease of
the correlation for high PaCO2 values has been previ-
ously reported. The accuracy of PtCO2 seems to be better
for patients with PaCO2 values below 56 mm Hg [26].
One explanation for this poor correlation is that the clini-
cal manifestations of hypercapnia (excessive sweating and
vasodilatation) leads to a lower diffusion of carbon dioxide
[26]. In our study, after multivariate analysis, temperature
was associated with a poor correlation between PaCO2
and PtCO2 (OR = 3.01; 95 % CIs [1.16, 7.80]; p = .03).
The issue that the temperature can influence the correla-
tion has been raised by Rodriguez et al. [27]. Our linear
regression analysis revealed that the higher the body tem-
perature, the greater the difference between PaCO2 and
PtCO2 values. This poor correlation can be explained by
the fact that asthe patient’s temperature increased, the dif-
ference between the patient and the temperature sensor
(44 °C) decreased, resulting in small changes in local per-
fusion and production of CO2. This hypothesis follows
directly from the operating principle of the sensor [6]. It
could also be hypothesized that a high body temperature
promotes sweating and vasodilatation making the sensor’s
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measurement more inaccurate. Finally, a low blood pres-
sure could also be a cause of a poor correlation between
PaCO2 and PtCO2 [28]. Unfortunately, this hypothesis
cannot be confirmed by our data because few patients had
shock criteria. Similarly, the assumption that the pH may
explain a poor correlation [21] cannot not be confirmed in
our study with the multivariate analysis.
Limitations
Although several studies have found a poor correlation
between PaCO2 and PtCO2 in patients with shock who are
treated with catecholamines [10], we did not analyze this
particular relationship. Indeed, we included few patients
with hemodynamic instability requiring the administra-
tion of intravenous fluids or vasopressor support. It is
therefore difficult to assess the impact of decreased cir-
culation on the correlation between PaCO2 and PtCO2.
Several studies have shown that the correlation is not
affected by catecholamines but by dermal vasoconstric-
tion secondary to a state of shock [23, 27].
Secondly, body mass index (BMI) was not measured
in our study. Several studies reported conflicting conclu-
sions regarding the influence of skin thickness, indirectly
estimated by BMI, on the CO2 diffusion to the skin and
therefore on the PaCO2 values [10, 23, 25, 26]. However,
there is no correlation between BMI and the skin on the
earlobe, where the sensor was fixed [29].
Finally, one subject that remains to be explored is the
intra-individual correlation. Most of the patients had only
one arterial blood gas measurement during their man-
agement in the RR, which was inadequate for obtaining
intra-individual correlations between different PtCO2 and
PaCO2 values. This analysis would be important to predict
PaCO2 values from continuous measurement of PtCO2,
especially for patients requiring several hours of monitor-
ing [27, 30].
Conclusions
There is a significant correlation between PaCO2 and
PtCO2 values for patients admitted to the ED for acute
respiratory failure. This correlation is particularly accu-
rate for values below 60 mm Hg. One limiting factor to
routine use of PtCO2 measurements in the ED is the
presence of hyperthermia.
Keymessages
• There is a significant correlation between PaCO2 and
PtCO2 values for patients admitted to the emergency
department for acute respiratory failure.
• This correlation is comparable to that which has
been shown in intensive care.
• One limiting factor to the use of PtCO2
measurements in the ED is the presence of
hyperthermia.
Appendix 1: Definition of Canadian triage and
acuity scale (CTAS) level 1 and level 2 for dyspnoea
Patients with dyspnoea and CTAS Level 1:
Severe respiratory distress: serious intracranial events,
pneumothorax, near death asthma (unable to speak,
cyanosis, lethargic/confused, tachycardia/bradycardia,
arterial oxygen saturation below 90 %), chronic
obstructive pulmonary disease exacerbations, cardiac
heart failure, anaphylaxis and severe metabolic disturb-
ances (renal failure, diabetic keto-acidosis).
Patients with dyspnoea and CTAS Level 2:
Asthma: severe asthma defined with a combination of
objectivesmeasures and clinical factors which relate to the
severity of symptoms, vital signs and history of previous
severe episodes. If the forced expiratory volume in 1 sec-
ond or peak expiratory flow rate are below 40 % predicted
or previous best, the patient is considered severe.
Dyspnea: this is subjective and may correlate poorly
with lung function or deficits in oxygen uptake and deliv-
ery. Depending on the age, previous history and physical
assessment one may not be able to distinguish between
asthma chronic obstructive pulmonary disease, cardiac
heart failure, pulmonary embolism, pneumothorax, pneu-
monia, croup, epiglottitis, anaphylaxis or a combination of
problems.
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Resuscitation room; PaCO2: Partial pressure of carbon dioxide in the blood;
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